Skip to content
WorldBrand.AI

Jingxiutang Pharmaceutical

Controversies

Controversies tied to this brand in public sources. A listing is not a finding of fault.

Back to profile1 entries

  1. 2018

    Cosmetics fail standards and draw fine; drug sampling test fails

    In 2018, the 'Fibronectin Repair Dual-Effect Combo' cosmetics produced by Guangzhou Baiyunshan Jingxiutang failed hygiene standards, and it was ordered to confiscate illegal gains and fined about 45,000 yuan; in 2023, its Tianhuang Houzao Powder failed the fill-weight variation test, and the National Medical Products Administration announced it and required suspension of sales and recall. Its cross-sector cosmetics were also accused by Legal Daily of suspected medicalized false advertising such as 'preventing myopia.' Fines, recall.

    Source